Layer, Chiang, et al. Genome Biology
Propelled by Strong Sequencing Business, Illumina's Revenues Grow 16 Percent in Q1
Illumina CEO Jay Flatley predicted that the number of installed next-generation sequencing platforms will eventually surpass that of capillary electrophoresis sequencers, estimated at about 15,000, as sequencing costs continue to decline and as applications expand.
New to GenomeWeb? Register here quickly.